title: An in vivo study of composite microgels based on hyaluronic acid and gelatin for the reconstruction of surgically injured rat vocal folds.
abstract: PURPOSE The objective of this study was to investigate local injection with a hierarchically microstructured hyaluronic acid-gelatin (HA-Ge) hydrogel for the treatment of acute vocal fold injury using a rat model. METHOD Vocal fold stripping was performed unilaterally in 108 Sprague-Dawley rats. A volume of 25 μl saline (placebo controls), HA-bulk, or HA-Ge hydrogel was injected into the lamina propria (LP) 5 days after surgery. The vocal folds were harvested at 3, 14, and 28 days after injection and analyzed using hematoxylin and eosin staining and immunohistochemistry staining for macrophages, myofibroblasts, elastin, collagen type I, and collagen type III. RESULTS The macrophage count was statistically significantly lower in the HA-Ge group than in the saline group (p &lt; .05) at Day 28. Results suggested that the HA-Ge injection did not induce inflammatory or rejection response. Myofibroblast counts and elastin were statistically insignificant across treatment groups at all time points. Increased elastin deposition was qualitatively observed in both HA groups from Day 3 to Day 28, and not in the saline group. Significantly more elastin was observed in the HA-bulk group than in the uninjured group at Day 28. Significantly more collagen type I was observed in the HA-bulk and HA-Ge groups than in the saline group (p &lt; .05) at Day 28. The collagen type I concentration in the HA-Ge and saline groups was found to be comparable to that in the uninjured controls at Day 28. The concentration of collagen type III in all treatment groups was similar to that in uninjured controls at Day 28. CONCLUSION Local HA-Ge and HA-bulk injections for acute injured vocal folds were biocompatible and did not induce adverse response.
authors.forename: Jiska M S
authors.initials: JM
authors.lastname: Coppoolse
authors.forename: T G
authors.initials: TG
authors.lastname: Van Kooten
authors.forename: Hossein K
authors.initials: HK
authors.lastname: Heris
authors.forename: Luc
authors.initials: L
authors.lastname: Mongeau
authors.forename: Nicole Y K
authors.initials: NY
authors.lastname: Li
authors.forename: Susan L
authors.initials: SL
authors.lastname: Thibeault
authors.forename: Jacob
authors.initials: J
authors.lastname: Pitaro
authors.forename: Olubunmi
authors.initials: O
authors.lastname: Akinpelu
authors.forename: Sam J
authors.initials: SJ
authors.lastname: Daniel
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology; D002921:Cicatrix / Q000276:immunology / Q000601:surgery; D004195:Disease Models, Animal; D005109:Extracellular Matrix / Q000276:immunology; D005780:Gelatin / Q000494:pharmacology*; D006820:Hyaluronic Acid / Q000494:pharmacology*; D020100:Hydrogels / Q000494:pharmacology*; D007827:Laryngitis / Q000276:immunology; D008297:Male; D011897:Random Allocation; D017207:Rats, Sprague-Dawley; D019651:Plastic Surgery Procedures / Q000379:methods*; D023822:Tissue Engineering / Q000379:methods; D014827:Vocal Cords / Q000276:immunology / Q000293:injuries* / Q000601:surgery*; D014945:Wound Healing / Q000187:drug effects / Q000276:immunology
chemical_list: D001672:Biocompatible Materials; D020100:Hydrogels; D005780:Gelatin; D006820:Hyaluronic Acid